Verrica Pharmaceuticals Inc.
VRCA
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 35.6 | 35.6 | 7.6 | 5.1 | 9.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 3.3 | 3.4 | 2.7 | 0.7 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 32.3 | 32.1 | 4.8 | 4.4 | 8.3 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 5.1 | 14.3 | 12.7 | 3.4 | 0.3 | -1.8 | 5.2 | 3.8 | 2.0 | 2.9 | |
| Cost of Revenues | 1.4 | 1.1 | 0.3 | 0.4 | 0.6 | 0.4 | 0.5 | 1.1 | 0.4 | 0.1 | |
| Gross Profit | 3.7 | 13.2 | 12.4 | 3.0 | -0.3 | -2.2 | 4.6 | 2.7 | 1.6 | 2.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 20.3 | 12.2 | 15.9 | 15.7 | 15.4 | 12.8 | 3.7 | 1.7 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 47.3 | 17.4 | 27.0 | 24.5 | 14.6 | 9.1 | 0.7 | 0.2 | |
| Depreciation & Amortization | 0.8 | 0.8 | 1.3 | 0.8 | 0.4 | 0.1 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Total Operating Expenses | 44.2 | 44.1 | 70.7 | 70.1 | 29.6 | 42.9 | 40.2 | 30.1 | 21.9 | 4.5 | 1.9 | |
| Operating Income | -11.9 | -11.9 | -65.9 | -65.8 | -21.3 | -30.9 | -40.2 | -30.1 | -21.9 | -4.5 | -1.9 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.3 | 6.5 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.9 | 20.1 | ||
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | ||
| Total Operating Expenses | 10.6 | 11.6 | 10.9 | 11.1 | 11.1 | 18.5 | 19.8 | 21.3 | 22.2 | 26.7 | ||
| Operating Income | -6.9 | 1.6 | 1.5 | -8.1 | -11.4 | -20.7 | -15.2 | -18.6 | -20.6 | -23.9 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.9 | 0.9 | 1.4 | 2.7 | 0.5 | 0.1 | 0.5 | 1.9 | 1.2 | 0.0 | 0.0 | |
| Interest Expense | 7.7 | 7.7 | 9.4 | 4.0 | 2.2 | 4.3 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -5.9 | -5.9 | -10.7 | -1.2 | -3.2 | -4.2 | -2.5 | 1.9 | 0.0 | 0.0 | 0.0 | |
| IBT | -17.9 | -17.9 | -76.6 | -67.0 | -24.5 | -35.1 | -42.7 | -28.2 | -20.6 | -4.5 | -1.9 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 3.2 | 3.8 | 2.8 | -0.3 | 1.2 | 0.0 | 0.0 | |
| Net Income | -17.9 | -17.9 | -76.6 | -67.0 | -27.7 | -38.9 | -45.5 | -28.0 | -20.6 | -4.5 | -1.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.4 | 0.6 | 0.8 | 0.8 | ||
| Interest Expense | 1.3 | 2.1 | 2.1 | 2.2 | 2.3 | 2.4 | 2.4 | 2.3 | 2.3 | 1.7 | ||
| Other Expense | -1.1 | -1.9 | -1.3 | -1.6 | -4.8 | -2.2 | -2.0 | -1.7 | -1.5 | -0.9 | ||
| IBT | -8.1 | -0.3 | 0.2 | -9.7 | -16.2 | -22.9 | -17.2 | -20.3 | -24.6 | -24.8 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | -0.4 | ||
| Net Income | -8.1 | -0.3 | 0.2 | -9.7 | -16.2 | -22.9 | -17.2 | -20.3 | -24.6 | -24.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-14.80 | $-8.10 | $-14.40 | $-18.20 | $-11.20 | $-14.10 | $-2.20 | $-0.96 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-14.80 | $-8.10 | $-14.40 | $-18.20 | $-11.20 | $-14.10 | $-2.20 | $-0.96 | |
| Shares Outstanding | 10.7 | 10.7 | 5.2 | 4.5 | 3.4 | 2.7 | 2.5 | 2.5 | 1.5 | 2.0 | 2.0 | |
| Diluted Shares Outstanding | 10.7 | 10.7 | 5.2 | 4.5 | 3.4 | 2.7 | 2.5 | 2.5 | 1.5 | 2.0 | 2.0 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-5.30 | $-5.40 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-5.30 | $-5.40 | ||
| Shares Outstanding | 10.7 | 9.5 | 9.5 | 9.5 | 6.7 | 4.7 | 4.7 | 4.6 | 4.6 | 4.6 | ||
| Diluted Shares Outstanding | 10.7 | 9.5 | 9.5 | 9.5 | 6.7 | 4.7 | 4.7 | 4.6 | 4.6 | 4.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 31.9 | 46.3 | 69.5 | 34.3 | 15.8 | 10.7 | 9.2 | 89.8 | 8.7 | 0.5 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 54.6 | 54.8 | 52.8 | 79.5 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 31.9 | 46.3 | 69.5 | 34.3 | 70.4 | 65.5 | 62.0 | 89.8 | 8.7 | 0.5 | |
| Accounts Receivable | 10.2 | 0.1 | 4.4 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 2.7 | 2.5 | 1.0 | -0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 2.5 | 2.3 | 2.5 | 4.8 | 4.0 | 2.2 | 3.0 | 1.3 | 0.4 | 0.0 | |
| Total Current Assets | 47.3 | 51.2 | 77.5 | 39.1 | 74.3 | 65.5 | 65.0 | 89.8 | 9.1 | 0.5 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 21.1 | 15.4 | 29.6 | 46.3 | 23.0 | 31.9 | 48.9 | 69.5 | 84.3 | 55.1 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 21.1 | 15.4 | 29.6 | 46.3 | 23.0 | 31.9 | 48.9 | 69.5 | 84.3 | 55.1 | |
| Accounts Receivable | 7.3 | 17.4 | 5.7 | 0.1 | 0.1 | 10.2 | 7.6 | 4.4 | 4.1 | 0.2 | |
| Inventory | 2.3 | 2.5 | 2.5 | 2.5 | 2.6 | 2.7 | 2.5 | 1.0 | 0.3 | 0.0 | |
| Other Current Assets | 5.5 | 1.5 | 1.8 | 2.3 | 2.6 | 2.5 | 2.3 | 2.5 | 3.1 | 1.5 | |
| Total Current Assets | 36.3 | 36.8 | 39.5 | 51.2 | 28.2 | 47.3 | 61.4 | 77.5 | 91.7 | 56.8 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 4.2 | 2.6 | 3.6 | 5.6 | 5.8 | 4.9 | 2.2 | 0.3 | 0.0 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.5 | 0.4 | 0.5 | 0.0 | 0.0 | 3.7 | 1.2 | 1.8 | 0.0 | 0.0 | |
| Total Long-Term Assets | 4.7 | 3.0 | 4.1 | 5.6 | 5.8 | 8.7 | 3.4 | 2.1 | 0.0 | 0.0 | |
| Total Assets | 52.0 | 54.1 | 81.6 | 44.7 | 80.1 | 74.2 | 68.4 | 91.9 | 9.1 | 0.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1.9 | 2.0 | 2.3 | 2.6 | 4.2 | 4.2 | 4.5 | 3.6 | 5.4 | 5.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 2.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.0 | 0.4 | |
| Total Long-Term Assets | 4.6 | 2.3 | 2.7 | 3.0 | 4.7 | 4.7 | 4.9 | 4.1 | 5.4 | 5.4 | |
| Total Assets | 40.9 | 39.1 | 42.2 | 54.1 | 32.9 | 52.0 | 66.3 | 81.6 | 97.1 | 62.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.2 | 1.9 | 2.5 | 0.5 | 0.8 | 0.3 | 1.2 | 1.0 | 0.2 | 0.1 | |
| Short-Term Debt | 1.1 | 13.6 | 1.4 | 0.3 | 41.9 | 35.5 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 17.9 | 13.5 | 13.2 | 2.7 | 3.3 | 3.1 | 2.0 | 1.5 | 0.4 | 0.3 | |
| Current Liabilities | 20.1 | 29.0 | 17.0 | 3.5 | 46.1 | 39.5 | 3.4 | 2.5 | 0.6 | 0.4 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.6 | 2.3 | 1.4 | 1.9 | 1.0 | 1.2 | 2.5 | 2.5 | 1.9 | 2.1 | |
| Short-Term Debt | 13.2 | 13.3 | 13.5 | 13.6 | 1.2 | 1.1 | 1.0 | 1.4 | 0.7 | 0.6 | |
| Other Current Liabilities | 12.6 | 13.1 | 14.5 | 13.5 | 18.9 | 17.9 | 15.8 | 13.2 | 8.8 | 3.1 | |
| Current Liabilities | 28.9 | 29.2 | 29.4 | 29.0 | 21.0 | 20.1 | 19.4 | 17.0 | 11.4 | 5.7 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 42.8 | 32.3 | 44.8 | 1.2 | 1.5 | 35.3 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 2.5 | 2.0 | 2.6 | 1.5 | 1.7 | 1.9 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 65.3 | 64.0 | 61.8 | 4.7 | 47.5 | 41.2 | 3.4 | 2.5 | 0.6 | 3.2 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1.0 | 25.6 | 29.0 | 32.3 | 46.0 | 45.3 | 45.4 | 44.8 | 43.5 | 1.1 | |
| Capital Leases | 1.7 | 1.6 | 1.8 | 2.0 | 3.8 | 2.5 | 2.6 | 1.9 | 1.4 | 1.4 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 57.9 | 56.6 | 60.8 | 64.0 | 67.0 | 65.3 | 64.8 | 61.8 | 54.8 | 6.8 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -268.0 | -307.0 | -230.4 | -163.5 | -139.0 | -103.9 | -61.2 | -33.1 | -12.4 | -2.7 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | -13.3 | -9.9 | 19.8 | 40.0 | 32.6 | 33.0 | 65.0 | 89.4 | 8.5 | -2.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -316.8 | -316.6 | -316.8 | -307.0 | -290.8 | -268.0 | -250.8 | -230.4 | -205.8 | -181.0 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | -17.0 | -17.5 | -18.6 | -9.9 | -34.1 | -13.3 | 1.5 | 19.8 | 42.3 | 55.4 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 46.3 | 45.9 | 45.5 | 1.5 | 43.4 | 35.3 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Book Value | -13.3 | -9.9 | 19.8 | 40.0 | 32.6 | 33.0 | 65.0 | 89.4 | 8.5 | -2.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -17.0 | -17.5 | -18.6 | -9.9 | -34.1 | -13.3 | 1.5 | 19.8 | 42.3 | 55.4 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -86.9 | -17.9 | -76.6 | -67.0 | -24.5 | -35.1 | -42.7 | -28.2 | -20.6 | -4.5 | -1.9 | |
| Depreciation & Amortization | 1.2 | 0.4 | 1.3 | 0.8 | 0.7 | 0.5 | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Stock-Based Compensation | 16.0 | 3.3 | 7.2 | 14.4 | 5.0 | 6.1 | 9.8 | 3.3 | 2.3 | 0.1 | 0.0 | |
| Change Working Capital | -0.5 | -6.3 | 2.0 | 9.9 | -1.8 | -0.5 | 1.6 | -1.7 | 0.9 | -0.2 | 0.3 | |
| Change In Accounts Receivable | -10.0 | -5.3 | 4.3 | -3.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -0.6 | 0.2 | -0.6 | 2.2 | -0.3 | 0.5 | -0.8 | 0.2 | 0.8 | 0.1 | 0.1 | |
| Change In Inventories | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 17.8 | 2.8 | 5.2 | 3.3 | 1.9 | 1.4 | 0.9 | -1.1 | -0.4 | 0.0 | 0.0 | |
| Cash from Operations | -65.8 | 0.0 | 0.0 | -38.6 | -18.7 | -27.6 | -30.2 | -27.4 | -17.9 | -4.6 | -1.6 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -8.1 | -0.3 | 0.2 | -9.7 | -16.2 | -22.9 | -17.2 | -20.3 | -24.6 | -24.8 | |
| Depreciation & Amortization | 0.2 | 0.2 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | |
| Stock-Based Compensation | 0.7 | 0.7 | 0.9 | 1.0 | 0.8 | 2.1 | 2.2 | 2.1 | 2.1 | 9.7 | |
| Change Working Capital | 2.0 | 7.9 | -11.6 | -4.6 | -4.1 | 11.0 | -2.4 | -2.5 | 4.6 | -0.3 | |
| Change In Accounts Receivable | 1.9 | 10.0 | -11.7 | -5.6 | -0.1 | 10.3 | -2.6 | -3.2 | -0.3 | -3.9 | |
| Change In Accounts Payable | 0.5 | -0.7 | 0.9 | -0.5 | 0.9 | -0.2 | -1.4 | 0.1 | 0.6 | 0.1 | |
| Change In Inventories | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.6 | 3.9 | |
| Other Non-cash Items | 0.6 | 1.1 | 0.4 | 0.4 | 3.2 | 0.8 | 0.7 | 0.5 | 5.1 | -1.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -14.7 | -14.8 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.3 | 0.0 | 0.0 | -0.4 | -0.3 | -0.9 | -1.5 | -0.7 | -0.8 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | -4.5 | -68.9 | -71.7 | -89.9 | -79.1 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 59.0 | 69.0 | 69.8 | 117.7 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.2 | -0.2 | -1.2 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -0.3 | 0.0 | 0.0 | -0.4 | 54.0 | -1.0 | -3.6 | 26.0 | -79.9 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.1 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -45.7 | 0.0 | 0.0 | 44.1 | -43.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 90.6 | 45.9 | 0.4 | 88.1 | 1.9 | 8.1 | 35.1 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.1 | 0.0 | 0.0 | 30.3 | 26.9 | 28.1 | 0.0 | 0.0 | 86.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 88.1 | 0.0 | 0.0 | -0.2 | 0.0 | 5.5 | 35.2 | 0.4 | 13.1 | 12.7 | 0.5 | |
| Cash from Financing | 42.9 | 0.0 | 0.0 | 74.2 | -16.9 | 33.6 | 35.2 | 0.4 | 99.4 | 12.7 | 0.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 44.1 | |
| Debt Issued | 14.1 | -24.8 | -3.5 | -3.5 | -1.2 | 0.8 | -0.1 | 0.9 | 1.7 | 86.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 44.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -23.2 | -16.2 | -23.2 | 35.3 | 18.5 | 5.1 | 1.4 | -1.0 | 1.6 | 8.1 | -1.1 | |
| Closing Cash Balance | 31.9 | 30.1 | 46.3 | 69.5 | 34.3 | 15.8 | 10.7 | 9.2 | 10.3 | 8.7 | 0.5 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 9.1 | 5.7 | -14.2 | -16.7 | 23.4 | -9.0 | -17.0 | -20.6 | -14.8 | 29.2 | |
| Closing Cash Balance | 30.1 | 21.1 | 15.4 | 29.6 | 46.3 | 23.0 | 31.9 | 48.9 | 69.5 | 84.3 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -66.2 | -17.6 | -61.0 | -38.9 | -19.0 | -28.5 | -31.7 | -28.1 | -18.6 | -4.6 | -1.6 | |
| Real Free Cash Flow | -82.2 | -20.9 | -68.1 | -53.3 | -23.9 | -34.5 | -41.5 | -31.4 | -20.9 | -4.7 | -1.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.6 | 9.7 | -10.0 | -12.7 | -16.1 | -8.6 | -16.4 | -19.9 | -15.0 | -14.9 | |
| Real Free Cash Flow | -5.3 | 9.0 | -10.9 | -13.7 | -16.8 | -10.7 | -18.6 | -22.0 | -17.0 | -24.5 |
